Bahram Valamehr - Chief R&D Officer at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Officer
Stock Symbol
FATE on Nasdaq
All Insider Reports
All Insider Reports

Bahram Valamehr - trading volume in the past year for Fate Therapeutics Inc

Holdings reported by Bahram Valamehr for Fate Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 358K $2.78M $7.77 Jul 29, 2024 Direct
Stock Option (Right to Buy) 450K $1.23M $2.73 Feb 1, 2024 Direct Common Stock

Transactions reported by Bahram Valamehr for Fate Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.